SLC26A4 · Western blot design guide

SLC26A4 Western Blot Planning Guide

Plan a SLC26A4 Western blot around the catalog-observed 85.7 kDa band, image-backed A00919-1 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for SLC26A4 (SLC26A4): expected band 85.7 kDa, antibody A00919-1, and guide-derived SDS-PAGE protocol steps
SLC26A4 Western blot protocol sheet — expected band 85.7 kDa, antibody A00919-1, controls and PMC citations. Open the full SLC26A4 WB guide →

SLC26A4 Western Blot Experimental Design Guide

Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 85.7 kDa
Observed band Not reported — verify product WB image
Gel 8-10%
Positive control ⓘ Thyroid gland
Negative control ⓘ Adrenal gland
Important caveats
Reasons your observed band may differ from the expected size.
ⓘ Calculated mass 85.7 kDa
ⓘ Localization Cell membrane / Apical cell membrane
ⓘ Processing / PTM Record-dependent
ⓘ Reactivity Human / Mouse / Rat
Section 1

Real Curated SLC26A4 Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateThyroid gland
Gel %8-10%
Load20-30 µg total protein per lane
TransferSemi-dry, standard transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryA00919-1 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected SLC26A4 Western Blot Band Size?

Use the product-observed 85.7 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
85.7 kDaMatches the authoritative product WB observation.
85.7 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected SLC26A4 appearancePlan around 85.7 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band85.7 kDa; use this as the primary experimental expectation.
Calculated mass85.7 kDa from UniProt O43511; retain as context.
Gel selection8-10%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with A00919-1.
Why is my band missing or off?
SituationLikely causeNext action
85.7 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for SLC26A4 Western blot

🧪Use Thyroid gland as the first positive-control candidate and Adrenal gland as the HPA Not detected negative candidate.
Positive control: Thyroid gland (Medium)
Negative control: Adrenal gland (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for SLC26A4

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Thyroid gland Reported tissue cells Medium Protein (HPA) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Adrenal gland Reported tissue cells Not detected Protein (HPA) HPA →
Appendix Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced SLC26A4 Western Blot Tips

Deeper troubleshooting and optimisation questions for SLC26A4, answered from its protein features.

Which band should guide the blot?
Use 85.7 kDa, the observation attached to the authoritative A00919-1 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 85.7 kDa expectation.
Which positive control should I start with?
Start with Thyroid gland, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Adrenal gland as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 8-10% consistently across the quick facts, protocol table, and poster.
What transfer method to use for SLC26A4 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should A00919-1 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents

SLC26A4 Western Blot Reagents

Human/Mouse/Rat-reactive SLC26A4 Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for SLC26A4 using A00919-1; observed band 85.7 kDa
Anti-SLC26A4 Antibody Picoband®
Cat # A00919-1

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.

References

  1. UniProt O43511
  2. Human Protein Atlas — SLC26A4
  3. A00919-1 product record
  4. PMC5788990 — The Balance of [Formula: see text] Secretion vs. Reabsorption in the Endometrial Epithelium Regulates Uterine Fluid pH (Frontiers in physiology, 2018)
  5. PMC10263427 — SLC26A4-AS1 Aggravates AngII-induced Cardiac Hypertrophy by Enhancing SLC26A4 Expression (Arquivos brasileiros de cardiologia, 2023)
  6. PMC3670936 — Differences in the pathogenicity of the p.H723R mutation of the common deafness-associated SLC26A4 gene in humans and mice (PloS one, 2014)